Share on StockTwits

American Vanguard Corp. (NYSE:AVD) was downgraded by Zacks from an “outperform” rating to an “underperform” rating in a research note issued on Monday, American Banking News reports. They currently have a $23.00 target price on the stock. Zacks‘ price target would indicate a potential downside of 4.80% from the company’s current price.

AVD has been the subject of a number of other recent research reports. Analysts at Feltl & Co. cut their price target on shares of American Vanguard Corp. from $34.38 to $30.70 in a research note to investors on Monday, December 23rd. They now have a “strong-buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $29.94.

Shares of American Vanguard Corp. (NYSE:AVD) traded up 0.67% on Monday, hitting $24.16. 162,607 shares of the company’s stock traded hands. American Vanguard Corp. has a one year low of $21.83 and a one year high of $34.97. The stock’s 50-day moving average is $25.08 and its 200-day moving average is $25.9. The company has a market cap of $692.4 million and a price-to-earnings ratio of 15.30.

American Vanguard Corp. (NYSE:AVD) last announced its earnings results on Thursday, October 31st. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.02. The company had revenue of $97.20 million for the quarter, compared to the consensus estimate of $94.78 million. During the same quarter in the previous year, the company posted $0.28 earnings per share. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. On average, analysts predict that American Vanguard Corp. will post $1.18 earnings per share for the current fiscal year.

American Vanguard Corporation operates as a holding company. It is primarily a chemical manufacturer that develops and markets products for agricultural and commercial uses.

To view Zacks’ full report, visit

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.